Strategy-confirming Study of BMS-955176 to Treat HIV-1 Infected Treatment-experienced Adults
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02386098 |
|
Recruitment Status
:
Terminated
(The trial ended early due to GI intolerability.)
First Posted
: March 11, 2015
Last Update Posted
: September 26, 2017
|
Sponsor:
ViiV Healthcare
Collaborator:
GlaxoSmithKline
Information provided by (Responsible Party):
ViiV Healthcare
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Terminated |
|---|---|
| Actual Primary Completion Date : | June 7, 2017 |
| Actual Study Completion Date : | June 7, 2017 |